Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Heat Treatment

Atlanta-based Altea Development is creating what has long been a diabetic’s fantasy: a system that delivers insulin through skin patches rather than by injection. First the patient places on his or her skin a handheld device bearing an array of tiny filaments. Each of the filaments delivers a three-millisecond burst of heat that vaporizes dead and dying cells and creates a micropore in the skin’s outer layer, which normally blocks absorption of large molecules such as insulin. Because the pulse of heat is too brief to affect the underlying living cells, the process is painless. The patient can then replace the device with an insulin-filled patch; for the next 24 hours, the insulin diffuses into the skin and is absorbed into the bloodstream. Alan Smith, Altea’s vice president of research, says that preliminary tests with human subjects have been successful, and he expects more extensive clinical trials to begin by the end of this year.

0 comments about this story. Start the discussion »

Tagged: Business

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me